{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:20:57Z","timestamp":1783437657592,"version":"3.54.6"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s12072-020-10107-0","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T18:02:59Z","timestamp":1609783379000},"page":"392-404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Elobixibat, an ileal bile acid transporter inhibitor, ameliorates non-alcoholic steatohepatitis in mice"],"prefix":"10.1007","volume":"15","author":[{"given":"Ryo","family":"Yamauchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Takedatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoko","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yotaro","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Kitaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomotaka","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoaki","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhide","family":"Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Morihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Takeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Shakado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Sakisaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihito","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"key":"10107_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","volume":"103","author":"JK Dowman","year":"2010","unstructured":"Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. QJM 2010;103:71\u201383","journal-title":"QJM"},{"key":"10107_CR2","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","volume":"377","author":"AM Diehl","year":"2017","unstructured":"Diehl AM, Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J 2017;377:2063\u20132072","journal-title":"N Engl J"},{"key":"10107_CR3","doi-asserted-by":"publisher","first-page":"114664","DOI":"10.1016\/j.taap.2019.114664","volume":"379","author":"T Suga","year":"2019","unstructured":"Suga T, Yamaguchi H, Ogura J, Shoji S, Maekawa M, Mano N. Altered bile acid composition and disposition in a mouse model of non-alcoholic steatohepatitis. Toxicol Appl Pharmacol 2019;379:114664","journal-title":"Toxicol Appl Pharmacol"},{"issue":"11","key":"10107_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.4254\/wjh.v9.i11.533","volume":"9","author":"C George","year":"2017","unstructured":"George C, Ronak P, Sandeep K, Sanjaya KS. Hepatocellular carcinoma in non-alcoholic steatohepatitis: current knowledge and implications for management. World J Hepatol 2017;9(11):533\u2013543","journal-title":"World J Hepatol"},{"issue":"3","key":"10107_CR5","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/cphy.c120023","volume":"3","author":"JY Chiang","year":"2013","unstructured":"Chiang JY. Bile acid metabolism and signaling. Compr Physiol 2013;3(3):1191\u20131212","journal-title":"Compr Physiol"},{"key":"10107_CR6","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/hep.29359","volume":"67","author":"P Puri","year":"2018","unstructured":"Puri P, Daita K, Joyce A, Mirshahi F, Santhekadur PK, Cazanave S, et al. The presence and severity of nonalcoholic steatosis associated with specific changes I circulating bile acids. Hepatology 2018;67:534\u2013548","journal-title":"Hepatology"},{"key":"10107_CR7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","volume":"60","author":"SC Kalhan","year":"2011","unstructured":"Kalhan SC, Guo L, Edmison J, Dasarathy S, McCllough AJ, Hanson RW, et al. Plasma metabolomic profile in nonalcoholic fatty liver disease. Metab Clin Exp 2011;60:404\u2013413","journal-title":"Metab Clin Exp"},{"issue":"1","key":"10107_CR8","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/hep.28709","volume":"65","author":"JP Arab","year":"2017","unstructured":"Arab JP, Karpen SJ, Dawson PA, Arrese M, Trauner M. Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives. Hepatology 2017;65(1):350\u2013362","journal-title":"Hepatology"},{"key":"10107_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/hep.27973","volume":"63","author":"AG Meithke","year":"2016","unstructured":"Meithke AG, Zhang W, Simmons J, Taylor AE, Shi T, Shanmukhappa SK, et al. Pharmacological inhibition of apical sodium dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice. Hepatology 2016;63:512\u2013523","journal-title":"Hepatology"},{"key":"10107_CR10","doi-asserted-by":"publisher","first-page":"357ra122","DOI":"10.1126\/scitranslmed.aaf4823","volume":"8","author":"A Rao","year":"2016","unstructured":"Rao A, Kosters A, Mells JE, Zhang W, Setchell KD, Amanso AM, et al. Inhibitor of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet fed mice. Sci Trasl Med 2016;8:357ra122","journal-title":"Sci Trasl Med."},{"key":"10107_CR11","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1194\/jlr.M200469-JLR200","volume":"44","author":"BG Bhant","year":"2003","unstructured":"Bhant BG, Rapp SR, Beaudty JA, Napawan N, Butteiger DN, Hall KA, et al. Inhibitition of ileal bile acid transport and reduced atherosclerosis in apoE-\/- mice by SC435. Lipid Res 2003;44:1614\u20131621","journal-title":"Lipid Res"},{"key":"10107_CR12","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3389\/fphar.2018.00931","volume":"9","author":"S Al-Dury","year":"2018","unstructured":"Al-Dury S, Marschall HU. Ileal bile acid transporter inhibition for the treatment of chronic constipation, cholestatic pruritus, and NASH. Front Pharmacol 2018;9:931","journal-title":"Front Pharmacol"},{"key":"10107_CR13","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.aohep.2019.04.006","volume":"18","author":"SMB Duarte","year":"2019","unstructured":"Duarte SMB, Stefano JT, Oliveira CP. Microbiota and nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis (NAFLD\/NASH). Ann Hepatol 2019;18:416\u2013421","journal-title":"Ann Hepatol"},{"key":"10107_CR14","doi-asserted-by":"publisher","first-page":"G518","DOI":"10.1152\/ajpgi.00024.2006","volume":"292","author":"P Brun","year":"2007","unstructured":"Brun P, Castagliuolo I, Leo DV, Buda A, Pinzani M, Palu G, et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007;292:G518\u2013G525","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10107_CR15","first-page":"57281","volume":"132","author":"Z Qiu","year":"2018","unstructured":"Qiu Z, Sheridan BS. Isolating lymphocytes from the mouse small intestinal immune system. J Vis Exp 2018;132:57281","journal-title":"J Vis Exp"},{"key":"10107_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2018.03.004","volume":"457","author":"G Gallo-Oller","year":"2018","unstructured":"Gallo-Oller G, Ordo\u00f1ez R, Dotor J. A new background subtraction method for Western blot densitometry band quantification through image analysis software. J Immunol Methods 2018;457:1\u20135","journal-title":"J Immunol Methods"},{"key":"10107_CR17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jhep.2017.04.026","volume":"67","author":"P Fickert","year":"2017","unstructured":"Fickert P, Wagner M. Biliary bile acids in hepatobiliary injury\u2014What is the link? J Hepatol 2017;67:619\u2013631","journal-title":"J. Hepatol."},{"key":"10107_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.tem.2017.11.002","volume":"29","author":"A Molinaro","year":"2018","unstructured":"Molinaro A, Wahlstrom A, Marschall HU. Role of bile acids in metabolic control. Trends Endocrinol Metab 2018;29:31\u201341","journal-title":"Trends Endocrinol Metab"},{"key":"10107_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/hep.25630","volume":"56","author":"N Tanaka","year":"2012","unstructured":"Tanaka N, Matsubara T, Krausz KW, Patterson AD, Gonzalez FJ. Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis. Hepatology 2012;56:118\u2013129","journal-title":"Hepatology"},{"key":"10107_CR20","doi-asserted-by":"publisher","first-page":"9925","DOI":"10.18632\/oncotarget.24066","volume":"11","author":"S Yamada","year":"2018","unstructured":"Yamada S, Takashima Y, Watanabe M, Nagamine R, Saito Y, Kamada N, et al. Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice. Oncotarget 2018;11:9925\u20139939","journal-title":"Oncotarget"},{"key":"10107_CR21","doi-asserted-by":"publisher","first-page":"e00131","DOI":"10.14309\/ctg.0000000000000131","volume":"11","author":"S Svenja","year":"2020","unstructured":"Svenja S, Jan B, et al. Altered microbiota diversity and bile acid signaling in cirrhotic and noncirrhotic NASH-HCC. Clin Transl Gastroenterol 2020;11:e00131","journal-title":"Clin Transl Gastroenterol"},{"key":"10107_CR22","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.3390\/ijms19103043","volume":"19","author":"K Saga","year":"2018","unstructured":"Saga K, Iwashita Y, Hidano S, Aso Y, Isaka K, Kido Y, et al. Secondary unconjugated bile acids induce hepatic stellate cell activation. Int J Mol Sci 2018;19:3043","journal-title":"Int J Mol Sci"},{"key":"10107_CR23","doi-asserted-by":"publisher","first-page":"12037","DOI":"10.1074\/jbc.M109.064808","volume":"285","author":"CR Weber","year":"2010","unstructured":"Weber CR, Raleigh DR, Su L, Shen L, Sullivan EA, Wang Y, et al. Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity. J Biol Chem 2010;285:12037\u201312046","journal-title":"J Biol Chem"},{"key":"10107_CR24","first-page":"10","volume":"11","author":"CR Weber","year":"2008","unstructured":"Weber CR, Nalle SC, Tretiakova M, Rubin DT, Tumer JR. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest 2008;11:10\u2013120","journal-title":"Lab Invest."},{"key":"10107_CR25","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1007\/s10620-011-1688-9","volume":"56","author":"LS Poritz","year":"2011","unstructured":"Poritz LS, HarrisKelly LRAA, Koltun WA. Increase in the tight junction protein claudin-1 in intestinal inflammation. Dig Dis Sci 2011;56:2802\u20132809","journal-title":"Dig Dis Sci"},{"key":"10107_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/01.shk.0000112346.38599.10","volume":"21","author":"X Han","year":"2004","unstructured":"Han X, Fink MP, Yang R, Delude RL. Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice. Shock 2004;21:261\u2013270","journal-title":"Shock"},{"key":"10107_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/nyas.13360","volume":"1397","author":"V Garcia-Hernandez","year":"2017","unstructured":"Garcia-Hernandez V, Quiros M, Nusrat A. Intestinal epithelial claudins: expression and regulation in homeostasis and inflammation. Ann NY Acad Sci 2017;1397:66\u201379","journal-title":"Ann NY Acad Sci"},{"key":"10107_CR28","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","volume":"444","author":"PJ Turnbaugh","year":"2006","unstructured":"Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027\u20131031","journal-title":"Nature"},{"key":"10107_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/advances\/nmx009","volume":"2","author":"H Liu","year":"2018","unstructured":"Liu H, Wang J, He T, Becker S, Zhang G, Li D, et al. Butyrate: a double-edged sword for health? Adv Nutr 2018;2:21\u201329","journal-title":"Adv Nutr."},{"issue":"8","key":"10107_CR30","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3390\/jcm8081089","volume":"8","author":"HN Kim","year":"2019","unstructured":"Kim HN, Joo EJ, Cheong HS, Kim Y, Kim HL, Shin H, Chang Y, Ryu S. Gut microbiota and risk of persistent nonalcoholic fatty liver disease. J Clin Med 2019;8(8):1089","journal-title":"J Clin Med"},{"issue":"1","key":"10107_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/mi.2016.75","volume":"10","author":"MY Zeng","year":"2017","unstructured":"Zeng MY, Inohara N, Nu\u00f1ez G. Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol 2017;10(1):18\u201326","journal-title":"Mucosal Immunol"},{"issue":"5","key":"10107_CR32","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/apt.15950","volume":"52","author":"N Misawa","year":"2020","unstructured":"Misawa N, Higurashi T, Takatsu T. The benefit of elobixibat in chronic constipation is associated with faecal deoxycholic acid but not effects of altered microbiota. Aliment Pharmacol Ther 2020;52(5):821\u2013828","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10107_CR33","doi-asserted-by":"publisher","first-page":"e00131","DOI":"10.14309\/ctg.0000000000000131","volume":"11","author":"S Sydor","year":"2020","unstructured":"Sydor S, Best J. Altered microbiota diversity and bile acid signaling in cirrhotic and noncirrhotic NASH-HCC. Clin Transl Gastroenterol 2020;11(3):e00131","journal-title":"Clin Transl Gastroenterol"},{"issue":"5","key":"10107_CR34","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1053\/j.gastro.2011.07.046","volume":"141","author":"KB Islam","year":"2011","unstructured":"Islam KB, Fukiya S, Hagio M, Fujii N, Ishizuka S, Ooka T, Ogura Y, et al. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 2011;141(5):1773\u20131181","journal-title":"Gastroenterology"},{"issue":"2","key":"10107_CR35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/apt.13457","volume":"43","author":"H Graffner","year":"2016","unstructured":"Graffner H, Gillberg PG, Rikner L, Marschall HU. The ileal bile acid transporter inhibitor A4250 decreases serum bile acids by interrupting the enterohepatic circulation. Aliment Pharmacol Ther 2016;43(2):303\u2013310","journal-title":"Aliment Pharmacol Ther"},{"key":"10107_CR36","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KI Donnelly","year":"2005","unstructured":"Donnelly KI, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted with lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005;115:1343\u20131351","journal-title":"J Clin Invest"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-020-10107-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-020-10107-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-020-10107-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T13:02:25Z","timestamp":1670677345000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-020-10107-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10107"],"URL":"https:\/\/doi.org\/10.1007\/s12072-020-10107-0","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"18 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving animals were in accordance with the ethical standards of the institution at which the studies were conducted and ethical approval was obtained from The Animal Care and Use Committee of Fukuoka University (Permit number: 2090). This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}